Differential Expression of Type III Effector BteA Protein Due to IS481 Insertion in Bordetella pertussis
2011

Differential Expression of BteA Protein in Bordetella pertussis

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Han Hyun-Ja, Kuwae Asaomi, Abe Akio, Arakawa Yoshichika, Kamachi Kazunari

Primary Institution: National Institute of Infectious Diseases, Tokyo, Japan

Hypothesis

The study investigates the differential expression of the BteA protein in Bordetella pertussis strains due to IS481 insertion.

Conclusion

BteA protein is expressed at higher levels in nonvaccine-type Bordetella pertussis strains compared to vaccine-type strains.

Supporting Evidence

  • BteA protein was detected at high levels in nonvaccine-type strains but not in vaccine-type strains.
  • An IS481 insertion was found in the 5' untranslated region of bteA in vaccine-type strains.
  • Quantitative RT-PCR showed differences in bteA transcript levels between strain types.

Takeaway

This study found that a protein called BteA is more common in certain types of bacteria that cause whooping cough, which might help explain why these bacteria are becoming more common.

Methodology

Proteomic analysis and immunoblotting were used to compare protein expression in clinical strains of Bordetella pertussis.

Limitations

The study primarily focuses on a limited number of strains and may not represent all circulating strains globally.

Participant Demographics

Clinical strains from Japan collected between 2002 and 2004.

Statistical Information

P-Value

0.11

Statistical Significance

p=0.11

Digital Object Identifier (DOI)

10.1371/journal.pone.0017797

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication